Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice

Immunology

Volumn 140, Issue 4, 2013, Pages 456-464

  Delarasse, Cecile ^a   Smith, Paul ^b   Baker, David ^c   Amor, Sandra ^b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

C57BL 6; Epitope; Experimental autoimmune encephalomyelitis; Mouse; Multiple sclerosis; Peptide

Indexed keywords

ENCEPHALITOGENIC PROTEIN; EPITOPE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RECOMBINANT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; T LYMPHOCYTE;

C57BL/6; EPITOPE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MOUSE; MULTIPLE SCLEROSIS; PEPTIDE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPE MAPPING; EPITOPES; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTES; TIME FACTORS;

EID: 84886612370     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12155     Document Type: Article

References (30)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372:1502-17.
2. van der Star BJ, Vogel DY, Kipp M, Puentes F, Baker D, Amor S. In vitro and in vivo models of multiple sclerosis. CNS Neurol Disord Drug Targets 2012; 11:570-88.
3. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153:4349-56.
4. Smith PA, Heijmans N, Ouwerling B et al. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur J Immunol 2005; 35:1311-9.
5. Jagessar SA, Smith PA, Blezer E et al. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. J Neuropathol Exp Neurol 2008; 67:326-40.
6. Linington C, Berger T, Perry L et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 1993; 23:1364-72.
7. Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A 2005; 102:13992-7.
8. Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2001; 36:220-34.
9. Delarasse C, Daubas P, Mars LT et al. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest 2003; 112:544-53.
10. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CC. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 1995; 154:5536-41.
11. Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur J Immunol 1995; 25:1951-9.
12. Levine S, Sowinski R. Experimental allergic encephalomyelitis in inbred and outbred mice. J Immunol 1973; 110:139-43.
13. Amor S, Smith PA, Hart B', Baker D. Biozzi mice: of mice and human neurological diseases. J Neuroimmunol 2005; 165:1-10.
14. Axtell RC, de Jong BA, Boniface K et al. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis. Nat Med 2010; 16:406-12.
15. Morris-Downes MM, McCormack K, Baker D, Sivaprasad D, Natkunarajah J, Amor S. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J Neuroimmunol 2002; 122:20-33.
16. Al-Izki S, Pryce G, O'Neill JK, Butter C, Giovannoni G, Amor S, Baker D. Practical guide to the induction of relapsing progressive experimental autoimmune ncephalomyelitis in the Biozzi ABH mouse. Mult Scler Rel Dis 2012; 1:29-38.
17. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin oligodendrocyte glycoprotein. Am J Pathol 1988; 130:443-54.
18. Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice. J Neuroimmunol 2002; 125:114-24.
19. Genain CP, Hauser SL. Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus. Immunol Rev 2001; 183:159-72.
20. Kerlero de Rosbo N, Mendel I, Ben-Nun A. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur J Immunol 1995; 25:985-93.
21. Villoslada P, Abel K, Heald N, Goertsches R, Hauser SL, Genain CP. Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates. Eur J Immunol 2001; 31:2942-50.
22. Rich C, Link JM, Zamora A et al. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur J Immunol 2004; 34:1251-61.
23. Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012; 79:1273-7.
24. Selter RC, Brilot F, Grummel V, Kraus V, Cepok S, Dale RC, Hemmer B. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology 2010; 74:1711-5.
25. Delarasse C, Della Gaspera B, Lu CW et al. Complex alternative splicing of the myelin oligodendrocyte glycoprotein gene is unique to human and non-human primates. J Neurochem 2006; 989:1707-17.
26. Oliver AR, Lyon GM, Ruddle NH. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J Immunol 2003; 171:462-8.
27. Linington C, Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinatating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 1987; 17:61-9.
28. Lalive PH, Menge T, Delarasse C et al. Native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci U S A 2006; 103:2280-5.
29. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001; 166:7579-87.
30. Ortega SB, Kashi VP, Tyler AF, Cunnusamy K, Mendoza JP, Karandikar NJ. The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis. J Immunol 2013; 191:117-26.